References

1. Angtuaco EJ, Fassas AB,Walker R, et al. Multiple myeloma: clinical review and diagnostic imaging. Radiology. 2004; 231(1):11-23. PubMed | Google Scholar


2. Palmbach M, Hoffmann W, Grodd W, et al. Extra osseous, epidural tumor spread of multiple myeloma. Eur J Radiol. 1996; 22(22):146-8. PubMed | Google Scholar


3. Bertheau P, Steinberg SM,CowanK, Merino MJ. Breast cancer in young women: clinicopathologic correlation. Semin Diagn Pathol. 1999; 16(3):248-56. PubMed | Google Scholar


4. S´ebastien Maillard and al. Innovative drug delivery nanosystems improve the anti-tumor activity in vitro and in vivo of anti-estrogens in human breast cancer and multiple myeloma. Journal of Steroid Biochemistry & Molecular Biology. 2005; 94: 111121. PubMed | Google Scholar


5. Shah IA, Haddad FS, Gani OS, Afsen CC. An association between renal cell carcinoma and lymphoid malignancies. Cancer. 1997; 80(5): 1005-6. PubMed | Google Scholar


6. Sakai A, Kawano M, Kuramoto A. Interleukind produced by renal carcinoma cells and progression of multiple myeloma. New Eng J Med. 1991; 324(26): 1893-4. PubMed | Google Scholar


7. Travis LB, Curtis RE, Boice JD, Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin’s lymphoma. Cancer. 1991 ; 67(7): 2002-9. Travis LB, Curtis RE, Boice JD, Hankey BF, Fraumeni JF Jr. Second cancers following non-Hodgkin’s lymphoma. Cancer. 1991 ; 67 : 2002-9. PubMed | Google Scholar


8. Otzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996; 335(12): 865-75. PubMed | Google Scholar